Homeobox protein MSX-2 (MSX2)

Homeobox protein MSX-2 (MSX2) is a highly conserved transcription factor belonging to the muscle segment homeobox (msh) gene family, encoded by the *MSX2* gene. MSX2 primarily acts as a transcriptional repressor, although it can also activate certain genes, and is essential for craniofacial and limb development, bone formation, and regulation of stem cell differentiation. The gene plays a central role in establishing a balance between survival and apoptosis in neural crest-derived cells, orchestrating craniofacial morphogenesis. MSX2 is a direct target of bone morphogenetic protein (BMP) signaling and integrates with the Wnt pathway during early embryogenesis to regulate mesendoderm differentiation. It mediates effects such as epithelial-mesenchymal transition (EMT) by downregulating E-cadherin and upregulating mesenchymal markers, impacting cell migration and tissue patterning. Mutations in *MSX2* are clinically significant, causing disorders such as craniosynostosis (premature fusion of skull bones) and enlarged parietal foramina. Due to its critical developmental roles and potential links to proliferative diseases, MSX2 is considered a functionally important transcription factor and developmental target, although currently not subject to direct pharmacological modulation[1][2][3].

Other names

Homeobox protein Hox-8HOX8CRS2FPPMSHPFMPFM1Craniosynostosis type 2 proteinmsh homeobox homolog 2muscle segment homeobox 2Parietal foramina 1 protein

not established for clinical drugs; experimentally, genetic or pathway modulation (e.g., inhibition or overexpression affects differentiation and proliferation pathways)